Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
3814093
Reference Type
Journal Article
Title
[Determination of roxithromycin in serum by high-performance liquid chromatography with ultraviolet detection]
Author(s)
Qin, Y; Zou, Y; Liang, M; Huang, Y; Yu, Q; Feng, P
Year
2001
Is Peer Reviewed?
0
Journal
Huaxi Yike Daxue Xuebao / Journal of West China University of Medical Sciences
ISSN:
0257-7712
Volume
32
Issue
4
Page Numbers
612-614
Language
Chinese
PMID
12528565
Abstract
OBJECTIVE:
To make better the RP-HPLC method for the determination of roxithromycin(RM) in human serum.
METHODS:
RM and clarithromycin (internal standard) were extracted from alkalinized serum sample (500 microliters) with methylene chloride. After evaporation of the organic layer, the residue was dissolved in 100 microliters of acetonitrile-ammonium phosphate (1:1, pH 6.0) and washed with n-hexane, then 20 microliters was injected onto a column (5 microns, 15 cm x 4.6 mm) of Penomenex luna C18. The mobile phase was acetonitrile-0.05 mol/L phosphoric acid (39:19:42, adjusted to pH 7.2 with ammonia water) pumped at 1.2 ml/min through the column. The variable wavelength UV detector operated at 0.01 aufs and the wavelength was set at 210 nm.
RESULTS:
The retention times for RM and clarithromycin were 4.4 min and 5.0 min, respectively. Standard curve was linear in the concentration range of 0.25 to 32 mg/L. The detection limit in serum was 0.06 mg/L; the average method recovery 97.4%; the inter-day RSD less than 3.0%.
CONCLUSION:
This method was found to be simple, rapid, sensitive and accurate for determination of RM in human serum.
Keywords
Roxithromycin; RP-HPLC; Serum drug concentration
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity